Patent classifications
A61F9/00781
INTRAOCULAR DRUG DELIVERY
An ab externo method of placing an intraocular implant into an eye can include advancing a needle, in which the implant is disposed, into the eye through conjunctiva and sclera of the eye. The implant can include a drug deliverable to the eye. The implant can thereafter be released to be anchored in the eye and elute the drug to the eye.
APPARATUS AND METHODS FOR TREATING EXCESS INTRAOCULAR FLUID
An ocular drainage system is provided for treating diseases that produce elevated intraocular pressures, such as glaucoma, wherein the system includes an implantable device and an external control unit, the implantable device includes a non-invasively adjustable valve featuring at least one deformable tube and a disk rotatably mounted within a housing, such that rotation of the disk using the external control unit causes the disk to apply a selected amount of compression to the deformable tube, thereby adjusting the fluidic resistance of the deformable tube and regulating the intraocular pressure.
HIGH RESOLUTION 3D PRINTING PROCESS OF COMPLEX STRUCTURES
A printing process of high resolution, preferably medical, devices with complex geometries is described, comprising the steps of: printing a model (1) with a three-dimensional printing method by using a three-dimensional printer; said model (1) positive reproducing the medical device (10) to be made; - said model (1) being printed of a first water-soluble polymer (2) or aqueous solutions; covering said model (1) with a layer of material (3) insoluble to a solution able to dissolve said first soluble polymer (2); said covering step making a shell of solid mold (7) provided with a surface comprising empty interstitial spots; - infiltrating an amount of water or aqueous solution into said solid mold through said empty interstitial spots so that to dissolve said model (1) and to make a mold cavity (8) negative reproducing said model (1); - infiltrating into the mold
OCULAR DELIVERY SYSTEMS AND METHODS
Described here are systems and methods for accessing Schlemm's canal, for delivering a fluid composition therein, and for tearing the trabecular meshwork. The fluid composition may be a viscoelastic fluid that is delivered into the canal to facilitate drainage of aqueous humor by disrupting the canal and surrounding trabeculocanalicular tissues. The systems described here may be configured to cut or tear the trabecular meshwork with the body of an elongate member located within Schlemm's canal.
Methods and Systems for Creating a Fluid and Pressure Equilibrium Between the Sub-Arachnoid Space and the Intraocular Compartment
A method for controlling intraocular pressure in a patient’s eye is provided. The method includes creating an intraocular entry into the eye, selecting a location along an optical disc of the eye, creating a conduit connecting at least a portion of an intravitreal cavity with at least a portion of a subarachnoid space in the eye at the selected location, deploying at least one stent communicating between the intravitreal cavity and the subarachnoid space via the conduit, and equilibrating the intraocular pressure in the eye by allowing the stent to communicate fluid flow between the intraocular compartment and the subarachnoid space.
OPTHALMIC MICROSURGICAL INSTRUMENT
In some embodiments, a microsurgical instrument includes a trocar having a rigid, hollow shaft formed with a lumen extending from a proximal end to a distal end of the shaft. The distal end of the shaft may be shaped for tissue penetration. The instrument may further include a composite microcannula slidably engaged with the trocar in the lumen. The microcannula includes a light guide and a flexible hollow tube having an outer diameter less than an inner diameter of the lumen in the trocar. Other embodiments include placing the microcannula in the lumen of the trocar, illuminating the end of the trocar by illuminating the end of the microcannula, advancing the trocar from a selected entry point on an eye into a selected structure in the eye, and extending the illuminated end of the microcannula from the trocar into the selected structure.
Bleb control glaucoma shunts
An implantable glaucoma shunt for treating glaucoma in an eye is disclosed herein. The glaucoma shunt may comprise a plurality of strips adapted to be positioned on a sclera of the eye and an elastomeric drainage tube having an outflow end connected to the plurality of strips and an opening thereof. The drainage tube may have an open lumen and a length sufficient to extend into the anterior chamber of the eye. The plurality of strips may be substantially parallel with one another or the plurality of strips may diverge from one another. In an embodiment, the disclosed glaucoma shunt may be manufactured by removing material from a prior-art type glaucoma shunt. The disclosed glaucoma shunt may be inserted via an insertion tool.
Combination treatment using ELT
A method of treating a subject having glaucoma comprises performing excimer laser trabeculostomy (ELT) on a subject having glaucoma and having previously undergone a failed treatment or a treatment that has been rendered ineffective by progression of the disease. In some examples, the failed treatment is a non-surgical treatment comprising administering medicated eye drops. In some examples, the failed treatment is a laser treatment or surgical treatment, such as a trabeculoplasty, iridotomy, iridectomy, trabeculectomy, trabeculotomy, goniotomy, surgical insertion of a shunt or implant, deep sclerectomy, viscocanalostomy, or a combination thereof.
Method and apparatus for implant in the conventional aqueous humor outflow pathway of a mammalian eye
An aqueous humor outflow device includes an arcuate scaffold that fits within a conventional aqueous humor outflow pathway of a mammalian eye to receive aqueous humor from a trabecular meshwork of the mammalian eye and allow flow of the aqueous humor through the arcuate scaffold to one or more collector channels that originate in a posterior wall of a Schlemm's canal. The arcuate scaffold includes a first arcuate rail, and a second arcuate rail spaced apart from, and substantially parallel to, the first arcuate rail. The first and second arcuate rails each have an anterior edge that is adjacent to the trabecular meshwork when inserted in the Schlemm's canal, and a posterior edge that is adjacent to the posterior wall of the Schlemm's canal. Structural components coupled to the first arcuate rail and the second arcuate rail maintain the respective anterior and posterior edges of the first and second arcuate rails spaced apart from, and substantially parallel to, each other.
METHOD FOR PRODUCING AN IMPLANT FOR INSERTING INTO AN EYE, IN PARTICULAR FOR INSERTING INTO THE SCHLEMM'S CANAL OF AN EYE
Exemplary arrangements relate to a method for producing an implant, in particular an implant configured to be inserted into a Schlemm's canal of an eye, which includes the steps of providing an implant blank, which implant blank is comprised of material that is permeable to laser radiation. The method further includes subjecting at least one region of the implant blank to laser radiation. Subsequent to subjecting the least one region to radiation, the method further includes removing material from the at least one region via fluid etching.